Achal Singh Achrol, MD
Director, Neurovascular Surgery; Director, Neurosurgery Clinical Trials Program; Chief, Glioma Surgery Program
About Dr. Achrol
Achal Singh Achrol, MD, is the Director of Neurovascular Surgery and Neurosurgery Clinical Trials Program at the Pacific Neuroscience Institute and Chief of the Glioma Surgery Program at the John Wayne Cancer Institute at Providence Saint John’s Health Center.
Dr. Achrol specializes in computer-assisted minimally invasive keyhole and microvascular neurosurgery, using advanced neuroimaging and stereotactic navigation techniques to safely reach even the most difficult lesions. As an academic neurosurgeon and physician scientist, Dr. Achrol is committed to leading translational research programs that advance treatment options for patients suffering from brain tumors, stroke, intracranial aneurysms and vascular malformations.
As the Director of Neurovascular Surgery, Dr. Achrol works closely with specialists in stroke neurology, interventional neuroradiology and neurocritical care to offer a team-based approach to the personalized, comprehensive care of patients with stroke, brain aneurysms and vascular malformations. The neurovascular program offers minimally invasive endovascular treatments, keyhole/microvascular neurosurgery and non-invasive adjuvant therapies.
As Chief of the Glioma Surgery Program, Dr. Achrol leads a translational research team committed to improving the quality of life and overall outcomes for patients through state-of-the-art treatments and advanced clinical trials. Dr. Achrol evaluates patients using a team-based approach that includes specialists in neurology, oncology, genetics, radiation oncology, head and neck surgery (ENT) and neuro-radiology. This broad expertise allows the Glioma Surgery Program to offer patient’s the most advanced personalized medicine treatments and precision therapy clinical trials, including immunotherapy (check point inhibitors, cancer vaccines, oncolytic virus therapy), stem cell therapies and genome-guided targeted molecular therapies.
Dr. Achrol has published extensively in the medical literature, routinely lectures nationally and internationally, and has received numerous awards for his work, including the prestigious Mahaley Award for Best Neuro-oncology Research from the Congress of Neurological Surgeons (CNS) and National Brain Tumor Society (NBTS), the Academy Award of the American Academy of Neurological Surgery for best neuroscience research, and the Best Research Awards from both the California Association of Neurological Surgeons (CANS) and the Western Neurosurgical Society (WNS).
Dr. Achrol has evaluated thousands of patients with brain tumors, strokes and vascular malformations, and directly participated in neurosurgical operations for the treatment of these patients. In 2003, Dr. Achrol was recruited by Dr. William L. Young, MD, to the Center for Cerebrovascular Research at the University of California, San Francisco (UCSF), where he served as lead investigator in the neurovascular genetics program, including the first genetics outcome studies for risk of complication from neurosurgery and risk of rupture in patient’s harboring neurovascular malformations. Dr. Achrol completed his training at Stanford University where he attended medical school and neurosurgery residency with an enfolded post-doctoral fellowship in neurosurgical oncology with Dr. Griffith R. Harsh, IV, MD, under an R25 award from the National Institutes of Health (NIH) and National Institute of Neurological Disorders and Stroke (NINDS).
In addition, Dr. Achrol’s other honors include the Stanford University Alpha Omega Alpha (AOA) Medical Honors Society Award, Stanford Society of Physicians Scholar Honors Society Award, Soros Foundation Academic Honors Fellowship Award, Stanford Department of Radiology Angel Award, Stanford Medical Scholars Award, Open Mind Neurosurgical International (OMNI) Innovator Award, Stanford Medical School’s Outstanding Mentor Award, Leslie Munzer Neurological Institute Award, Hearst Foundation Award, Cyberknife Society Award, and the John Hanbery Award of the Stanford Neurosurgery Department (Neurosurgery Chairman’s Award).